4.7 Article

Expression of the selenoprotein S (SELS) gene m subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 60, Issue 1, Pages 114-120

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2010.05.011

Keywords

-

Funding

  1. Knut and Alice Wallenberg Foundation
  2. Swedish Research Council [K2009-65X-15424-05, K2010-55X-11285-13]
  3. Swedish foundation for Strategic Research
  4. Swedish Diabetes foundation
  5. Ake Wiberg foundation
  6. foundations of the National Board of Health and Welfare
  7. Jeansson foundations
  8. Magnus Bergvall foundation
  9. Tore Nilson foundation
  10. Royal Physiographic Society
  11. VINNOVA-VINNMER program
  12. Swedish federal government
  13. Swedish Knowledge Foundation
  14. Wellcome Trust [GR079534]
  15. MRC [G0700342] Funding Source: UKRI
  16. Medical Research Council [G0700342] Funding Source: researchfish

Ask authors/readers for more resources

The selenoprotein S (SELS) is a putative receptor for serum amyloid A, and recent studies have suggested that SELS may be a link between type 2 diabetes mellitus and inflammation Genetic studies of SELS polymorphisms have revealed associations with circulating levels of inflammatory markers and hard end points of cardiovascular disease In this study, we analyzed SELS expression in subcutaneous adipose tissue and SELS genotype in relation to metabolic risk factors DNA microarray expression analysis was used to study the expression of SELS in lean and obese siblings from the Swedish Obese Subjects Sib Pair Study TaqMan genotyping was used to analyze 3 polymorphisms, previously found to be associated with circulating levels of inflammatory markers, in the INTERGENE case-control study of myocardial infarction and unstable angina pectoris Possible associations between SELS genotype and/or expression with anthropometry and measures of metabolic status were investigated Real-time polymerase chain reaction was used to analyze the SELS expression m isolated human adipocytes incubated with insulin In lean subjects, we found correlations between SELS gene expression in subcutaneous adipose tissue and measures of obesity (waist, P = 045, sagittal diameter P = 031) and blood pressure (diastolic, P = 016, systolic P = 015), and in obese subjects, we found correlations with measures of obesity (body mass index, P = 03, sagittal diameter, P = 008) and glycemic control (homeostasis model assessment of insulin resistance, P = 011, insulin, P = 009) after adjusting for age and sex The 5227GG genotype was associated with serum levels of insulin (P = 006) and homeostasis model assessment of insulin resistance (P = 007) The expression of SELS increased after insulin stimulation in isolated human adipocytes (P = 008) In this study, we found an association between both SELS gene expression in adipose tissue and SELS genotype with measures of glycemic control In vitro studies demonstrated that the SELS gene is regulated by insulin in human subcutaneous adipocytes This study further supports a role for SELS in the development of metabolic disease, especially in the context of insulin resistance (C) 2011 Elsevier Inc All rights reserved

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

How has the future investment program stimulated research and innovation in health?

Regis Bordet, Jean-Christophe Dantonel, Eric Vacaresse, Claire Le Jeunne, Nora Benhabiles, Alain Beretz, Christian Boitard, Stephanie Debette, Gilles Duluc, Philippe Froguel, Benedicte Garbil, Stanislas Lyonnet, Abderrahim Mahfoudi, Pierre Marquet, Franck Mouthon, Olivier Rascol, Vincent Richard, Emmanuelle Simon, Nathalie Varoqueaux, Herve Watiert, Marie Zinsu

Summary: This article explores the impact of the Investments for the Future programme on health research and innovation, identifying five key factors for future development in healthcare innovation.

THERAPIE (2022)

Article Cell Biology

Glucose Regulates m6A Methylation of RNA in Pancreatic Islets

Florine Bornaque, Clement Philippe Delannoy, Emilie Courty, Nabil Rabhi, Charlene Carney, Laure Rolland, Maeva Moreno, Xavier Gromada, Cyril Bourouh, Pauline Petit, Emmanuelle Durand, Francois Pattou, Julie Kerr-Conte, Philippe Froguel, Amelie Bonnefond, Frederik Oger, Jean-Sebastien Annicotte

Summary: This study found that environmental variations, such as glucose concentration, can control m(6)A methylation in pancreatic beta cells, modulating gene expression and pancreatic beta-cell functions. These findings provide new insights into the causes and mechanisms of type 2 diabetes.

CELLS (2022)

Article Biochemistry & Molecular Biology

Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes

Natalia Pervjakova, Gunn-Helen Moen, Maria-Carolina Borges, Teresa Ferreira, James P. Cook, Catherine Allard, Robin N. Beaumont, Mickael Canouil, Gad Hatem, Anni Heiskala, Anni Joensuu, Ville Karhunen, Soo Heon Kwak, Frederick T. J. Lin, Jun Liu, Sheryl Rifas-Shiman, Claudia H. Tam, Wing Hung Tam, Gudmar Thorleifsson, Toby Andrew, Juha Auvinen, Bishwajit Bhowmik, Amelie Bonnefond, Fabien Delahaye, Ayse Demirkan, Philippe Froguel, Kadri Haller-Kikkatalo, Hildur Hardardottir, Sandra Hummel, Akhtar Hussain, Eero Kajantie, Elina Keikkala, Amna Khamis, Jari Lahti, Tove Lekva, Sanna Mustaniemi, Christine Sommer, Aili Tagoma, Evangelia Tzala, Raivo Uibo, Marja Vaarasmaki, Pia M. Villa, Kare Birkeland, Luigi Bouchard, Cornelia M. Duijn, Sarah Finer, Leif Groop, Esa Hamalainen, Geoffrey M. Hayes, Graham A. Hitman, Hak C. Jang, Marjo-Riitta Jarvelin, Anne Karen Jenum, Hannele Laivuori, Ronald C. Ma, Olle Melander, Emily Oken, Kyong Soo Park, Patrice Perron, Rashmi B. Prasad, Elisabeth Qvigstad, Sylvain Sebert, Kari Stefansson, Valgerdur Steinthorsdottir, Tiinamaija Tuomi, Marie-France Hivert, Paul W. Franks, Mark McCarthy, Cecilia M. Lindgren, Rachel M. Freathy, Deborah A. Lawlor, Andrew P. Morris, Reedik Magi

Summary: The study found that gestational diabetes mellitus (GDM) and type 2 diabetes (T2D) share the same underlying pathology, but there are also genetic determinants specific to glucose regulation in pregnancy.

HUMAN MOLECULAR GENETICS (2022)

Article Orthopedics

Bariatric surgery, osteoarthritis and arthroplasty of the hip and knee in Swedish Obese Subjects-up to 31 years follow-up of a controlled intervention study

L. S. Lohmander, M. Peltonen, J. C. Andersson-Assarsson, C. Maglio, K. Sjoholm, M. Taube, P. Jacobson, P-A. Svensson, L. M. S. Carlsson, S. Ahlin

Summary: This study investigated the long-term effect of obesity and bariatric surgery on the incidences of osteoarthritis and arthroplasty of hip and knee. The results showed that the bariatric surgery group had a lower incidence of hip osteoarthritis but a higher incidence of knee arthroplasty compared to the control group.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Medicine, General & Internal

Monogenic diabetes

Amelie Bonnefond, Ranjit Unnikrishnan, Alessandro Doria, Martine Vaxillaire, Rohit N. Kulkarni, Viswanathan Mohan, Vincenzo Trischitta, Philippe Froguel

Summary: Monogenic diabetes encompasses several clinical conditions characterized by early-onset diabetes, including neonatal diabetes, maturity-onset diabetes of the young (MODY) and diabetes-associated syndromes. It can be misdiagnosed as type 2 diabetes, and different genetic variations can lead to different forms of diabetes. Precision medicine approaches and next-generation sequencing have improved diagnosis and treatment options.

NATURE REVIEWS DISEASE PRIMERS (2023)

Article Cell Biology

High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry

Clement Philippe Delannoy, Egon Heuson, Adrien Herledan, Frederik Oger, Bryan Thiroux, Mickael Chevalier, Xavier Gromada, Laure Rolland, Philippe Froguel, Benoit Deprez, Sebastien Paul, Jean-Sebastien Annicotte

Summary: Type 2 diabetes is a metabolic disorder affecting over 537 million people worldwide, characterized by loss of pancreatic beta-cell function and insulin resistance. Long-term control of glycemia is challenging, highlighting the need for new drugs and targets to improve beta-cell function and insulin secretion. In this study, a high-throughput screening method using automated cellular assays and mass spectrometry was developed, identifying potential regulators of insulin secretion and synthesis among siRNA and chemical compounds.

CELLS (2023)

Article Cell Biology

Knocking Down CDKN2A in 3D hiPSC-Derived Brown Adipose Progenitors Potentiates Differentiation, Oxidative Metabolism and Browning Process

Yasmina Kahoul, Xi Yao, Frederik Oger, Maeva Moreno, Souhila Amanzougarene, Mehdi Derhourhi, Emmanuelle Durand, Raphael Boutry, Amelie Bonnefond, Philippe Froguel, Christian Dani, Jean-Sebastien Annicotte, Christophe Breton

Summary: Human induced pluripotent stem cells (hiPSCs) have the potential to differentiate into any cell type, making them relevant for therapeutic applications. In particular, they hold promise for obesity treatment by providing an unlimited source of brown/beige adipose progenitors (hiPSC-BAPs). However, the limited differentiation potential of brown/beige adipocytes in 2D cultures poses a challenge for clinical use.

CELLS (2023)

Article Endocrinology & Metabolism

Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese Subjects

Lena M. S. Carlsson, Bjorn Carlsson, Peter Jacobson, Cecilia Karlsson, Johanna C. Andersson-Assarsson, Felipe M. Kristensson, Sofie Ahlin, Per-Arne Svensson, Magdalena Taube, Ingmar Naeslund, Kristjan Karason, Markku Peltonen, Kajsa Sjoholm

Summary: A study in Sweden found that bariatric surgery is associated with increased life expectancy and reduced overall mortality, regardless of whether patients had baseline type 2 diabetes (T2D) or not.

INTERNATIONAL JOURNAL OF OBESITY (2023)

Article Endocrinology & Metabolism

Non-alcohol substance use disorder after bariatric surgery in the prospective, controlled Swedish Obese Subjects study

Per-Arne Svensson, Markku Peltonen, Johanna C. Andersson-Assarsson, Sofie Ahlin, Petra Brembeck, My Engstrom, Peter Jacobson, Magdalena Taube, Kajsa Sjoholm, Lena M. S. Carlsson

Summary: This study aimed to investigate the association between bariatric surgery and substance use disorder (SUD) with substances other than alcohol. The results showed that gastric bypass surgery was associated with an increased risk of non-alcohol SUD. This finding should be taken into consideration in long-term postoperative care.

OBESITY (2023)

Article Cardiac & Cardiovascular Systems

Lipid Levels During Adult Lifetime in Men and Women With and Without a Subsequent Incident Myocardial Infarction: A Longitudinal Analysis of Data From the Tromso Study 1974 to 2016

Grethe Albrektsen, Tom Wilsgaard, Ivar Heuch, Maja-Lisa Lochen, Dag Steinar Thelle, Inger Njolstad, Sameline Grimsgaard, Kaare Harald Bonaa

Summary: Adverse lipid levels can be seen 20 to 35 years before the occurrence of myocardial infarction, especially in relation to high-density lipoprotein cholesterol and triglyceride levels. This trend is more pronounced in women. However, the difference in mean lipid levels between myocardial infarction patients and the general population is not significant for both genders.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Endocrinology & Metabolism

Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study

Lise Folon, Morgane Baron, Benedicte Toussaint, Emmanuel Vaillant, Mathilde Boissel, Victoria Scherrer, Helene Loiselle, Audrey Leloire, Alaa Badreddine, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Soulaimane Aboulouard, Michel Salzet, Mickael Canouil, Mehdi Derhourhi, Philippe Froguel, Amelie Bonnefond

Summary: Rare biallelic pathogenic mutations in PCSK1 cause early-onset obesity and other endocrinopathies. Functional genomic study shows that rare heterozygous variants of PCSK1 can also impact obesity risk.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Meeting Abstract Endocrinology & Metabolism

Role of GWAS associated purinergic receptor P2RY1 gene in insulin secretion and the impact of rare variants on type 2 diabetes risk

A. Dance, M. Derhourhi, M. Canouil, M. Marre, G. Charpentier, A. Bonnefond, P. Froguel

DIABETOLOGIA (2022)

Meeting Abstract Endocrinology & Metabolism

Impact of rare heterozygous mutations of PCSK1 on obesity: implication for treatment with MC4R agonists

L. Folon, M. Baron, M. Derhourhi, B. Balkau, G. Charpentier, S. Franc, R. Roussel, M. Canouil, P. Froguel, A. Bonnefond

DIABETOLOGIA (2022)

Meeting Abstract Endocrinology & Metabolism

Impact of type 2 diabetes-associated variants at the SLC30A8 locus on transcriptional activity and function of human b cells and super-enhancer at SLC30A8 gene locus

M. Hu, I. Kim, M. Canouil, S. Bonas-Guarch, A. A. Khamis, J. Ferrer, P. Froguel, G. R. Rutter

DIABETOLOGIA (2022)

Article Endocrinology & Metabolism

Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation

Emilie Steinbach, Davide Masi, Agnes Ribeiro, Patricia Serradas, Tiphaine Le Roy, Karine Clement

Summary: The study of the gut microbiome is crucial for understanding and treating metabolic diseases. While research on the fecal microbiome has provided valuable insights, relying solely on this may not be enough to draw comprehensive conclusions. The microbiome in the proximal part of the small intestine may play a significant role in metabolic regulation, but further exploration is needed due to limited accessibility.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4

Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Burak Soysal, Ilaria Cosentini, Sameer Parashar, Anuvrat Sircar, Giovanni Nigita, Lalit Sehgal, Michael A. Freitas, Philip N. Tsichlis

Summary: This study reveals the important role of KDM2B in triple-negative breast cancer (TNBC). KDM2B affects cellular resistance to oxidative stress by regulating a network of genes and metabolic enzymes, in collaboration with ATF4 and MYC. Additionally, high expression of KDM2B is associated with poor prognosis in patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Statin therapy in individuals with intermediate cardiovascular risk

Joongmin Kim, Hyeongsoo Kim, Sang Hyun Park, Yura Kang, Kyungdo Han, Sang-Hak Lee

Summary: This study aimed to investigate the optimal LDL-C level after statin therapy in individuals with intermediate cardiovascular risk. The results showed that achieving LDL-C levels <120 mg/dL after statin therapy could lower the event risk.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease

Ze Chen, Li -Ping Xia, Lang Shen, Dan Xu, Yu Guo, Hui Wang

Summary: Accumulating evidence suggests that NAFLD has an intrauterine origin, with adverse prenatal environments and glucocorticoid exposure playing a crucial role in the developmental programming of fetal hepatic lipid metabolism. The offspring's glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis is programmed in utero, leading to postnatal catch-up growth and disrupted glucose and lipid metabolism, increasing susceptibility to NAFLD. Mismatch between intrauterine and postnatal environments can further disturb the programmed endocrine axes and accelerate the onset of NAFLD.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease

Fuwen Zuo, Youzhao Wang, Xinlei Xu, Ruihao Ding, Wei Tang, Yu Sun, Xiaojie Wang, Yan Zhang, Jichao Wu, Yusheng Xie, Min Liu, Ziying Wang, Fan Yi

Summary: This study investigates the role of CCDC92 in the pathogenesis of diabetic kidney disease (DKD). The expression of CCDC92 was found to increase in kidney biopsies from patients with DKD and was correlated with glomerular lipid accumulation. Animal studies further confirmed the induction of CCDC92 in the kidney, particularly in podocytes, and the podocyte-specific deletion of Ccdc92 ameliorated podocyte injury and lipid deposition. CCDC92 was shown to promote podocyte lipotoxicity through ABCA1 signaling-mediated lipid homeostasis. Therefore, CCDC92 may serve as a potential biomarker of podocyte injury in DKD and targeting CCDC92 could be an innovative therapeutic strategy for DKD patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Brown adipose tissue-derived metabolites and their role in regulating metabolism

Khanyisani Ziqubu, Phiwayinkosi Dludla, Sihle E. Mabhida, Babalwa U. Jack, Susanne Keipert, Martin Jastroch, Sithandiwe E. Mazibuko-Mbeje

Summary: The discovery and revival of brown adipose tissue (BAT) in adult humans have opened up new possibilities for treating obesity and metabolic diseases. BAT not only plays a role in generating heat, but also secretes signaling molecules known as batokines, which regulate overall metabolism. This review highlights the importance of BAT-derived metabolites in controlling thermogenesis, substrate metabolism, and other biological processes, as well as their potential to alleviate obesity and related metabolic complications.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)